colorectal cancer

By Laura Lovett April 17, 2018
A new clinical validation study, published in the Journal of Clinical Oncology CCI, found that Medial EarlySign’s artificial intelligence tool flagged about 8 percent of patients in a large trial group that were later diagnosed with cancer or precancerous lesions.  “The implementation of machine-learning based algorithms to risk stratify populations at risk is commonly feared by many clinicians...
By Dave Muoio March 6, 2018
A trio of presenters at HIMSS 2018 shared data from practical machine learning and AI-focused studies that demonstrate how the technologies could reduce costs and improve patients’ outcomes.  These studies, conducted by teams at the Grady Health System, Kaiser Permanente, and the University of Pittsburgh Medical Center, primarily focused on flagging adult and pediatric patients whose EHRs...
By Heather Mack August 9, 2016
Israel-based Check-Cap, a clinical stage medical diagnostics company that is working on an ingestible sensor capsule to screen for colorectal cancer, has entered into an agreement with a single healthcare company for $5.9 million in financing. Check-Cap, which does not have a commercial product as of yet, will use the net proceeds from the offering to advance the ongoing clinical development of...

Editor's Pick